z-logo
Premium
Colposcopic and histologic findings in women with a cytologic diagnosis of atypical squamous cells of undetermined significance
Author(s) -
YARANDI Fariba,
IZADI MOOD Narges,
MIRASHRAFI Fatemeh,
EFTEKHAR Zahra
Publication year - 2004
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.2004.00299.x
Subject(s) - ascus (bryozoa) , colposcopy , squamous intraepithelial lesion , medicine , gynecology , cervix , cytology , biopsy , population , cervical intraepithelial neoplasia , not otherwise specified , cervical cancer , cancer , pathology , botany , ascospore , spore , environmental health , biology
Background: The optimal method for managing a patient diagnosed with atypical squamous cells of undetermined significance (ASCUS) has not yet been established. The interim guidelines published by the National Cancer Institute suggest that a patient should be referred for colposcopy after the second ASCUS diagnosis within 2 years. Aim: To assess the significance of ASCUS in predicting the presence of underlying squamous intraepithelial lesion (SIL) of the uterine cervix. Study population: Women undergoing colposcopy for ASCUS cytology at a teaching hospital in Tehran University, in the years 1998–2001, considered eligible to enter this retrospective study. Results: Of the 266 patients who underwent colposcopy, 28 (11%) had low‐grade squamous intraepithelial lesion (LSIL), 16 (6.3%) had high‐grade squamous intraepithelial lesion (HSIL) two (0.8%) had squamous cell carcinoma (SCC), and 48 (18.8%) had flat condyloma. Conclusion: Atypical squamous cells of undetermined significance (ASCUS) on a cervical smear is a good marker for detecting underlying SIL and condyloma. Thus, immediate colposcopy and directed biopsy are appropriate follow‐up procedures.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here